A simple and cost-effective HPLC-UV method for the detection of levetiracetam in plasma/serum of patients with epilepsy

被引:16
作者
Engelbrecht, Lynette [1 ]
Grobler, C. J. [2 ]
Rheeders, Malie [1 ]
机构
[1] North West Univ, Sch Pharm Pharmacol, Clin Pharmacokinet Lab, Potchefstroom, South Africa
[2] Vaal Univ Technol, Dept Hlth Sci, Vanderbijlpark, South Africa
关键词
different blood collection tubes; epilepsy; HPLC; human plasma; serum; levetiracetam; TANDEM MASS-SPECTROMETRY; NEWER ANTIEPILEPTIC DRUGS; CHROMATOGRAPHY; PERFORMANCE; PHARMACOKINETICS; BLOOD; SERUM;
D O I
10.1002/bmc.3969
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple, fast and cost-effective method was developed and validated for the determination of levetiracetam (LEV) in plasma/serum of patients using high performance liquid chromatography (HPLC) with ultraviolet detection. The stability of LEV plasma/serum samples over time and in different blood collection tubes was evaluated. Serum/plasma samples were deproteinized by methanol spiked with the internal standard, gabapentin. HPLC was carried out on a Venusil XBP C-18, 250x4.6mm, 5m column, at a flow rate of 1.0mL/min and with mobile phase consisting of 50mm potassium dihydrogen phosphate-acetonitrile at a pH of 5.5. The UV detector was set at 205nm and 10L was injected. Total runtime was 15min. Calibration curves were linear (correlation coefficient=0.999) over a concentration range of 1-60g/mL. Relative standard deviation values for both the inter-day and intra-day precision and accuracy were <5% for the concentration range. The influence of different collection tubes and the effect of time on the stability of LEV was investigated. These factors may cause inaccuracies owing to drug-protein binding and interference in the matrix. This method is simple, fast, cost-effective, reliable and accurate with minimal sample preparation for daily routine use in therapeutic drug monitoring.
引用
收藏
页数:9
相关论文
共 32 条
[1]  
[Anonymous], 2013, Guidance for Industry: Bioanalytical method validation
[2]   Interferences from blood collection tube components on clinical chemistry assays [J].
Bowen, Raffick A. R. ;
Remaley, Alan T. .
BIOCHEMIA MEDICA, 2014, 24 (01) :31-44
[3]   Simple and validated HPLC-UV analysis of levetiracetam in deproteinized plasma of patients with epilepsy [J].
Contin, Manuela ;
Mohamed, Susan ;
Albani, Fiorenzo ;
Riva, Roberto ;
Baruzzi, Agostino .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2008, 873 (01) :129-132
[4]   Spectrofluorimetric Determination of Topiramate and Levetiracetam as Single Components in Tablet Formulations and in Human Plasma and Simultaneous Fourth Derivative Synchronous Fluorescence Determination of their Co-Adminstered Mixture in Human Plasma [J].
El-Yazbi, A. F. ;
Wagih, M. M. ;
Ibrahim, F. ;
Barary, M. A. .
JOURNAL OF FLUORESCENCE, 2016, 26 (04) :1225-1238
[5]  
European Medicines Agency, 2011, GUID BIOAN METH VAL
[6]   Determination of levetiracetam in human plasma/serum/saliva by liquid chromatography-electro spray tandem mass spectrometry [J].
Guo, Tiedong ;
Oswald, Lisa M. ;
Mendu, Damodara Rao ;
Soldin, Steven J. .
CLINICA CHIMICA ACTA, 2007, 375 (1-2) :115-118
[7]  
Hansen H. S., 2012, INTRO PHARM CHEM ANA, P173
[8]   Sensitive inexpensive HPLC determination of four antiepileptic drugs in human plasma: application to PK studies [J].
Ibrahim, Fawzia A. ;
El-Yazbi, Amira F. ;
Barary, Magda A. ;
Wagih, Mira M. .
BIOANALYSIS, 2016, 8 (21) :2219-2234
[9]  
International Conference on Harmonization, 2015, TOP QA R2 STAB TEST
[10]   Enantioselective analysis of levetiracetam and its enantiomer R-α-ethyl-2-oxo-pyrrolidine acetamide using gas chromatography and ion trap mass spectrometric detection [J].
Isoherranen, N ;
Roeder, M ;
Soback, S ;
Yagen, B ;
Schurig, V ;
Bialer, M .
JOURNAL OF CHROMATOGRAPHY B, 2000, 745 (02) :325-332